+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pharmaceutical Grade 1,3-Propanediol Market - Global Forecast to 2030- Product Image
Pharmaceutical Grade 1,3-Propanediol Market - Global Forecast to 2030- Product Image
Sale

Pharmaceutical Grade 1,3-Propanediol Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 197 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6140753
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Pharmaceutical grade propanediol is gaining traction as a critical excipient in advanced drug formulations, with sustainability-focused innovations and evolving regulatory demands shaping both supply chains and competitive positioning. As global adoption intensifies, senior decision-makers are actively reevaluating sourcing, technology, and partnership strategies to maintain a resilient, future-ready portfolio.

Market Snapshot: Strategic Landscape of Pharmaceutical Grade Propanediol

The global market for pharmaceutical grade propanediol—also known as a three-carbon diol—continues its upward trajectory, supported by rising demand for high-purity excipients in modern drug delivery. The market’s momentum is reinforced by accelerating R&D in excipient technology, rapid adoption within specialized applications, and the ongoing conversion to renewable, bio-based feedstocks. Interest is notably high across industries seeking both functional superiority and adherence to shifting environmental and regulatory standards. With regions such as the Americas, EMEA, and Asia-Pacific navigating distinct growth drivers and regulations, value chain players recognize the importance of tailoring operational strategies to maximize efficiency and supply assurance.

Scope & Segmentation: In-Depth Coverage of the Pharmaceutical Grade Propanediol Market

  • End-Use Industries: Personal care, pharmaceuticals, polymers
  • Applications: Coating agents, emollients, humectants, polymer precursors, solvents
  • Production Processes: Bio-based fermentation from corn or glycerol, petroleum-based synthesis via acrolein hydration or propylene oxidation
  • Distribution Channels: Direct sales, distributor sales, e-commerce
  • Packaging Types: Bulk tanker, drum, intermediate bulk container
  • Regional Coverage: Americas (including United States: California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio; Canada; Mexico; Brazil; Argentina), EMEA (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Key Companies: DuPont Tate & Lyle Biomaterials LLC, Cargill Incorporated, Royal DSM N.V., BASF SE, Mitsubishi Gas Chemical Company Inc., Ashland Global Holdings Inc., Zhejiang NHU Co. Ltd., CJ CheilJedang Corporation, Samyang Corporation, Evonik Industries AG

Key Takeaways for Senior Decision-Makers

  • Pharmaceutical grade propanediol’s multifunctional profile—combining solvent efficiency, low toxicity, and biocompatibility—continues to drive its adoption in drug formulation, personal care, and polymer applications.
  • Bio-based production methods now account for an increasing proportion of supply, as stakeholders prioritize reduced carbon footprints and regulatory compliance.
  • Advances in digital validation, supply chain traceability, and blockchain technology are enhancing transparency and aligning with the heightened scrutiny from global regulatory agencies.
  • Market players are navigating complex global landscapes by forging regional manufacturing partnerships and diversifying sourcing to mitigate the implications of trade disruptions and import tariffs observed in the U.S. market.
  • Investment in innovative R&D and new purification processes remains central, with companies leveraging technology-led differentiation and rapid response to evolving therapeutic demands.
  • Sustainability commitments and lifecycle management practices are increasingly influencing procurement, customer loyalty, and competitive advantage in both established and emerging regions.

Tariff Impact: Navigating Shifting Trade Dynamics

Revisions to U.S. import levies have compelled pharmaceutical companies to reassess sourcing strategies and supply resilience. This has led to greater attention towards domestic and regional production options, increased storage capacity, and enhanced collaboration with North American partners. These adjustments often require additional working capital and operational resources. Over time, such shifts are expected to reinforce the value of regional manufacturing hubs and reduce exposure to policy volatility.

Methodology & Data Sources

This analysis integrates qualitative and quantitative approaches, combining secondary research from peer-reviewed publications, industry white papers, patent documents, and financial disclosures. Extensive primary research through interviews and surveys with value chain stakeholders further validates findings. Quality is maintained through continuous peer reviews and expert audits, ensuring a robust, transparent foundation for market insights.

Why This Report Matters

  • Empowers leaders to optimize sourcing, technological adoption, and regulatory compliance strategies in a rapidly evolving market.
  • Supports risk mitigation and cost efficiency through actionable insights into sustainability, regional trends, and supply chain transformations.
  • Enables better targeting of high-value applications and identification of partnerships aligned with organizational growth and environmental priorities.

Conclusion

As competition intensifies and regulatory landscapes shift, leaders equipped with a strategic understanding of the pharmaceutical grade propanediol market can secure operational resilience, capitalize on innovation, and ensure long-term value creation. Data-driven insights are essential for navigating complexity and capturing future growth.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rapid adoption of bio-based fermentation routes to produce high-purity pharmaceutical grade 1,3-propanediol for excipient manufacturing
5.2. Strategic collaborations between biotech firms and API producers to scale up sustainable 1,3-propanediol supply chains for parenteral formulations
5.3. Increasing regulatory approvals of drug master files supporting the use of 1,3-propanediol in novel drug delivery systems and inhalation therapies
5.4. Advances in downstream purification technologies to achieve tighter impurity profiles for injectable 1,3-propanediol in sterile pharmaceutical applications
5.5. Price volatility driven by fluctuation in renewable feedstock availability impacting pharmaceutical-grade 1,3-propanediol margins
5.6. Rising demand for green excipients in clean-label pharmaceuticals boosting investments in renewable 1,3-propanediol production facilities
5.7. Expansion of regional manufacturing hubs in Asia Pacific to address local demand for pharmaceutical grade 1,3-propanediol in dermatological formulations
5.8. Patent expirations on key 1,3-propanediol fermentation processes catalyzing generic supplier entry and price competition in the pharmaceutical sector
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Pharmaceutical Grade 1,3-Propanediol Market, by End-Use Industry
8.1. Introduction
8.2. Personal Care
8.3. Pharmaceuticals
8.4. Polymers
9. Pharmaceutical Grade 1,3-Propanediol Market, by Application
9.1. Introduction
9.2. Coating Agent
9.3. Emollient
9.4. Humectant
9.5. Polymer Precursor
9.6. Solvent
10. Pharmaceutical Grade 1,3-Propanediol Market, by Production Process
10.1. Introduction
10.2. Bio Based Fermentation
10.2.1. Corn Derived
10.2.2. Glycerol Derived
10.3. Petroleum Based Synthesis
10.3.1. Acrolein Hydration
10.3.2. Propylene Oxidation
11. Pharmaceutical Grade 1,3-Propanediol Market, by Distribution Channel
11.1. Introduction
11.2. Direct Sales
11.3. Distributor Sales
11.4. E Commerce
12. Pharmaceutical Grade 1,3-Propanediol Market, by Packaging Type
12.1. Introduction
12.2. Bulk Tanker
12.3. Drum
12.4. Intermediate Bulk Container
13. Americas Pharmaceutical Grade 1,3-Propanediol Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Pharmaceutical Grade 1,3-Propanediol Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Pharmaceutical Grade 1,3-Propanediol Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. DuPont Tate & Lyle Biomaterials LLC
16.3.2. Cargill, Incorporated
16.3.3. Royal DSM N.V.
16.3.4. BASF SE
16.3.5. Mitsubishi Gas Chemical Company, Inc.
16.3.6. Ashland Global Holdings Inc.
16.3.7. Zhejiang NHU Co., Ltd.
16.3.8. CJ CheilJedang Corporation
16.3.9. Samyang Corporation
16.3.10. Evonik Industries AG
17. Research AI18. Research Statistics19. Research Contacts20. Research Articles21. Appendix
List of Figures
FIGURE 1. PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY END-USE INDUSTRY, 2024 VS 2030 (%)
FIGURE 6. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY END-USE INDUSTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PRODUCTION PROCESS, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PRODUCTION PROCESS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PACKAGING TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PACKAGING TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET: RESEARCHAI
FIGURE 26. PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET: RESEARCHSTATISTICS
FIGURE 27. PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET: RESEARCHCONTACTS
FIGURE 28. PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY END-USE INDUSTRY, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY END-USE INDUSTRY, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PERSONAL CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PERSONAL CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY POLYMERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY POLYMERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY COATING AGENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY COATING AGENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY EMOLLIENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY EMOLLIENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY HUMECTANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY HUMECTANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY POLYMER PRECURSOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY POLYMER PRECURSOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY SOLVENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY SOLVENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PRODUCTION PROCESS, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PRODUCTION PROCESS, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY BIO BASED FERMENTATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY BIO BASED FERMENTATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY CORN DERIVED, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY CORN DERIVED, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY GLYCEROL DERIVED, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY GLYCEROL DERIVED, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY BIO BASED FERMENTATION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY BIO BASED FERMENTATION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PETROLEUM BASED SYNTHESIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PETROLEUM BASED SYNTHESIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY ACROLEIN HYDRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY ACROLEIN HYDRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PROPYLENE OXIDATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PROPYLENE OXIDATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PETROLEUM BASED SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PETROLEUM BASED SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY DISTRIBUTOR SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY DISTRIBUTOR SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY E COMMERCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY E COMMERCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY BULK TANKER, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY BULK TANKER, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY DRUM, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY DRUM, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY INTERMEDIATE BULK CONTAINER, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY INTERMEDIATE BULK CONTAINER, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY END-USE INDUSTRY, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY END-USE INDUSTRY, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PRODUCTION PROCESS, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PRODUCTION PROCESS, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY BIO BASED FERMENTATION, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY BIO BASED FERMENTATION, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PETROLEUM BASED SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PETROLEUM BASED SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY END-USE INDUSTRY, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY END-USE INDUSTRY, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PRODUCTION PROCESS, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PRODUCTION PROCESS, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY BIO BASED FERMENTATION, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY BIO BASED FERMENTATION, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PETROLEUM BASED SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PETROLEUM BASED SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 95. CANADA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY END-USE INDUSTRY, 2018-2024 (USD MILLION)
TABLE 96. CANADA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY END-USE INDUSTRY, 2025-2030 (USD MILLION)
TABLE 97. CANADA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 98. CANADA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 99. CANADA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PRODUCTION PROCESS, 2018-2024 (USD MILLION)
TABLE 100. CANADA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PRODUCTION PROCESS, 2025-2030 (USD MILLION)
TABLE 101. CANADA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY BIO BASED FERMENTATION, 2018-2024 (USD MILLION)
TABLE 102. CANADA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY BIO BASED FERMENTATION, 2025-2030 (USD MILLION)
TABLE 103. CANADA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PETROLEUM BASED SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 104. CANADA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PETROLEUM BASED SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 105. CANADA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 106. CANADA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 107. CANADA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 108. CANADA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 109. MEXICO PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY END-USE INDUSTRY, 2018-2024 (USD MILLION)
TABLE 110. MEXICO PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY END-USE INDUSTRY, 2025-2030 (USD MILLION)
TABLE 111. MEXICO PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 112. MEXICO PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 113. MEXICO PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PRODUCTION PROCESS, 2018-2024 (USD MILLION)
TABLE 114. MEXICO PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PRODUCTION PROCESS, 2025-2030 (USD MILLION)
TABLE 115. MEXICO PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY BIO BASED FERMENTATION, 2018-2024 (USD MILLION)
TABLE 116. MEXICO PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY BIO BASED FERMENTATION, 2025-2030 (USD MILLION)
TABLE 117. MEXICO PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PETROLEUM BASED SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 118. MEXICO PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PETROLEUM BASED SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 119. MEXICO PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 120. MEXICO PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 121. MEXICO PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 122. MEXICO PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 123. BRAZIL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY END-USE INDUSTRY, 2018-2024 (USD MILLION)
TABLE 124. BRAZIL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY END-USE INDUSTRY, 2025-2030 (USD MILLION)
TABLE 125. BRAZIL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 126. BRAZIL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 127. BRAZIL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PRODUCTION PROCESS, 2018-2024 (USD MILLION)
TABLE 128. BRAZIL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PRODUCTION PROCESS, 2025-2030 (USD MILLION)
TABLE 129. BRAZIL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY BIO BASED FERMENTATION, 2018-2024 (USD MILLION)
TABLE 130. BRAZIL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY BIO BASED FERMENTATION, 2025-2030 (USD MILLION)
TABLE 131. BRAZIL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PETROLEUM BASED SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 132. BRAZIL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PETROLEUM BASED SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 137. ARGENTINA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY END-USE INDUSTRY, 2018-2024 (USD MILLION)
TABLE 138. ARGENTINA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY END-USE INDUSTRY, 2025-2030 (USD MILLION)
TABLE 139. ARGENTINA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 140. ARGENTINA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 141. ARGENTINA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PRODUCTION PROCESS, 2018-2024 (USD MILLION)
TABLE 142. ARGENTINA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PRODUCTION PROCESS, 2025-2030 (USD MILLION)
TABLE 143. ARGENTINA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY BIO BASED FERMENTATION, 2018-2024 (USD MILLION)
TABLE 144. ARGENTINA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY BIO BASED FERMENTATION, 2025-2030 (USD MILLION)
TABLE 145. ARGENTINA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PETROLEUM BASED SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 146. ARGENTINA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PETROLEUM BASED SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 147. ARGENTINA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 148. ARGENTINA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 149. ARGENTINA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 150. ARGENTINA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY END-USE INDUSTRY, 2018-2024 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY END-USE INDUSTRY, 2025-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PRODUCTION PROCESS, 2018-2024 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PRODUCTION PROCESS, 2025-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY BIO BASED FERMENTATION, 2018-2024 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY BIO BASED FERMENTATION, 2025-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PETROLEUM BASED SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PETROLEUM BASED SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 167. UNITED KINGDOM PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY END-USE INDUSTRY, 2018-2024 (USD MILLION)
TABLE 168. UNITED KINGDOM PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY END-USE INDUSTRY, 2025-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 170. UNITED KINGDOM PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PRODUCTION PROCESS, 2018-2024 (USD MILLION)
TABLE 172. UNITED KINGDOM PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PRODUCTION PROCESS, 2025-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY BIO BASED FERMENTATION, 2018-2024 (USD MILLION)
TABLE 174. UNITED KINGDOM PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY BIO BASED FERMENTATION, 2025-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PETROLEUM BASED SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 176. UNITED KINGDOM PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PETROLEUM BASED SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 177. UNITED KINGDOM PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 178. UNITED KINGDOM PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 179. UNITED KINGDOM PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 180. UNITED KINGDOM PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 181. GERMANY PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY END-USE INDUSTRY, 2018-2024 (USD MILLION)
TABLE 182. GERMANY PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY END-USE INDUSTRY, 2025-2030 (USD MILLION)
TABLE 183. GERMANY PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 184. GERMANY PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 185. GERMANY PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PRODUCTION PROCESS, 2018-2024 (USD MILLION)
TABLE 186. GERMANY PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PRODUCTION PROCESS, 2025-2030 (USD MILLION)
TABLE 187. GERMANY PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY BIO BASED FERMENTATION, 2018-2024 (USD MILLION)
TABLE 188. GERMANY PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY BIO BASED FERMENTATION, 2025-2030 (USD MILLION)
TABLE 189. GERMANY PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PETROLEUM BASED SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 190. GERMANY PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PETROLEUM BASED SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 191. GERMANY PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 192. GERMANY PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 193. GERMANY PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 194. GERMANY PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 195. FRANCE PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY END-USE INDUSTRY, 2018-2024 (USD MILLION)
TABLE 196. FRANCE PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY END-USE INDUSTRY, 2025-2030 (USD MILLION)
TABLE 197. FRANCE PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 198. FRANCE PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 199. FRANCE PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PRODUCTION PROCESS, 2018-2024 (USD MILLION)
TABLE 200. FRANCE PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PRODUCTION PROCESS, 2025-2030 (USD MILLION)
TABLE 201. FRANCE PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY BIO BASED FERMENTATION, 2018-2024 (USD MILLION)
TABLE 202. FRANCE PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY BIO BASED FERMENTATION, 2025-2030 (USD MILLION)
TABLE 203. FRANCE PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PETROLEUM BASED SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 204. FRANCE PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PETROLEUM BASED SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 205. FRANCE PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 206. FRANCE PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 207. FRANCE PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 208. FRANCE PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 209. RUSSIA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY END-USE INDUSTRY, 2018-2024 (USD MILLION)
TABLE 210. RUSSIA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY END-USE INDUSTRY, 2025-2030 (USD MILLION)
TABLE 211. RUSSIA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 212. RUSSIA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 213. RUSSIA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PRODUCTION PROCESS, 2018-2024 (USD MILLION)
TABLE 214. RUSSIA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PRODUCTION PROCESS, 2025-2030 (USD MILLION)
TABLE 215. RUSSIA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY BIO BASED FERMENTATION, 2018-2024 (USD MILLION)
TABLE 216. RUSSIA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY BIO BASED FERMENTATION, 2025-2030 (USD MILLION)
TABLE 217. RUSSIA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PETROLEUM BASED SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 218. RUSSIA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PETROLEUM BASED SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 219. RUSSIA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 220. RUSSIA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 221. RUSSIA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 222. RUSSIA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 223. ITALY PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY END-USE INDUSTRY, 2018-2024 (USD MILLION)
TABLE 224. ITALY PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY END-USE INDUSTRY, 2025-2030 (USD MILLION)
TABLE 225. ITALY PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 226. ITALY PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 227. ITALY PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PRODUCTION PROCESS, 2018-2024 (USD MILLION)
TABLE 228. ITALY PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PRODUCTION PROCESS, 2025-2030 (USD MILLION)
TABLE 229. ITALY PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY BIO BASED FERMENTATION, 2018-2024 (USD MILLION)
TABLE 230. ITALY PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY BIO BASED FERMENTATION, 2025-2030 (USD MILLION)
TABLE 231. ITALY PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PETROLEUM BASED SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 232. ITALY PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PETROLEUM BASED SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 233. ITALY PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 234. ITALY PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 235. ITALY PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 236. ITALY PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 237. SPAIN PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY END-USE INDUSTRY, 2018-2024 (USD MILLION)
TABLE 238. SPAIN PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY END-USE INDUSTRY, 2025-2030 (USD MILLION)
TABLE 239. SPAIN PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 240. SPAIN PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 241. SPAIN PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PRODUCTION PROCESS, 2018-2024 (USD MILLION)
TABLE 242. SPAIN PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PRODUCTION PROCESS, 2025-2030 (USD MILLION)
TABLE 243. SPAIN PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY BIO BASED FERMENTATION, 2018-2024 (USD MILLION)
TABLE 244. SPAIN PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY BIO BASED FERMENTATION, 2025-2030 (USD MILLION)
TABLE 245. SPAIN PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PETROLEUM BASED SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 246. SPAIN PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PETROLEUM BASED SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 247. SPAIN PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 248. SPAIN PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 249. SPAIN PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 250. SPAIN PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 251. UNITED ARAB EMIRATES PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY END-USE INDUSTRY, 2018-2024 (USD MILLION)
TABLE 252. UNITED ARAB EMIRATES PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY END-USE INDUSTRY, 2025-2030 (USD MILLION)
TABLE 253. UNITED ARAB EMIRATES PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 254. UNITED ARAB EMIRATES PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 255. UNITED ARAB EMIRATES PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PRODUCTION PROCESS, 2018-2024 (USD MILLION)
TABLE 256. UNITED ARAB EMIRATES PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PRODUCTION PROCESS, 2025-2030 (USD MILLION)
TABLE 257. UNITED ARAB EMIRATES PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY BIO BASED FERMENTATION, 2018-2024 (USD MILLION)
TABLE 258. UNITED ARAB EMIRATES PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY BIO BASED FERMENTATION, 2025-2030 (USD MILLION)
TABLE 259. UNITED ARAB EMIRATES PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PETROLEUM BASED SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 260. UNITED ARAB EMIRATES PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PETROLEUM BASED SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 261. UNITED ARAB EMIRATES PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 262. UNITED ARAB EMIRATES PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 263. UNITED ARAB EMIRATES PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 264. UNITED ARAB EMIRATES PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 265. SAUDI ARABIA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY END-USE INDUSTRY, 2018-2024 (USD MILLION)
TABLE 266. SAUDI ARABIA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY END-USE INDUSTRY, 2025-2030 (USD MILLION)
TABLE 267. SAUDI ARABIA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 268. SAUDI ARABIA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 269. SAUDI ARABIA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PRODUCTION PROCESS, 2018-2024 (USD MILLION)
TABLE 270. SAUDI ARABIA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PRODUCTION PROCESS, 2025-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY BIO BASED FERMENTATION, 2018-2024 (USD MILLION)
TABLE 272. SAUDI ARABIA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY BIO BASED FERMENTATION, 2025-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PETROLEUM BASED SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 274. SAUDI ARABIA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PETROLEUM BASED SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 276. SAUDI ARABIA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 277. SAUDI ARABIA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 278. SAUDI ARABIA PHARMACEUTICAL GRADE 1,3-PROPANEDIOL MARKET SIZE

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Pharmaceutical Grade 1,3-Propanediol Market report include:
  • DuPont Tate & Lyle Biomaterials LLC
  • Cargill, Incorporated
  • Royal DSM N.V.
  • BASF SE
  • Mitsubishi Gas Chemical Company, Inc.
  • Ashland Global Holdings Inc.
  • Zhejiang NHU Co., Ltd.
  • CJ CheilJedang Corporation
  • Samyang Corporation
  • Evonik Industries AG

Related Topics

Related Reports

1,3-Propanediol Market - Global Forecast 2025-2030 - Product Image

1,3-Propanediol Market - Global Forecast 2025-2030

  • Report
  • 197 Pages
  • Global
From
1,3-Propanediol (PDO) Market Size Analysis Report - Market Share, Forecast Trends and Outlook (2025-2034) - Product Image

1,3-Propanediol (PDO) Market Size Analysis Report - Market Share, Forecast Trends and Outlook (2025-2034)

  • Report
  • 168 Pages
  • Global
From
1,3-Propanediol (PDO) - Global Strategic Business Report - Product Image

1,3-Propanediol (PDO) - Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From
2025 1,3 Propanediol (PDO) Market Outlook Report: Industry Size, Market Shares Data, Insights, Growth Trends, Opportunities, Competition 2024 to 2032 - Product Image

2025 1,3 Propanediol (PDO) Market Outlook Report: Industry Size, Market Shares Data, Insights, Growth Trends, Opportunities, Competition 2024 to 2032

  • Report
  • 154 Pages
  • Global
From
2-Methyl-1,3-propanediol (MPO) Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application - Product Image

2-Methyl-1,3-propanediol (MPO) Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application

  • Report
  • 78 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.